Top find peony-rose
HC is on the NODE again!
SH are awaiting an announcement on immunotherapy partnering and possibly a 20 million dollar kicker, I would have thought HC would have had more interest in the real value of the AI company. ADMEDUS's IP in AI is I believe a lot more valuable than what the market is valuing it at and I mean a lot richer.
The HOT SPOT, immuno-oncology where multinational companies are spending billions of dollars on if we mix this with that it should work. On theory alone.
This was were, previous management relied on CR to complete phase one instead of partnering and ended up destroying their credibility, which is still lingering.
PS. Remember its a PLATFORM TECHNOLOGY just like ADAPT only different.
Admedus Immunotherapy Deal, page-93
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $217.7M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $82.02K | 7.947K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1118 | $10.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.35 | 1082 | 3 |
View Market Depth
| Last trade - 14.03pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |